{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:57:29Z","timestamp":1792267049625,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00616"],"award-info":[{"award-number":["PI22\/00616"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02973-6","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:41:06Z","timestamp":1784526066000},"page":"3079-3090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolomic signatures of glycemic control in type 1 diabetes: insights from continuous glucose monitoring"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4244-9581","authenticated-orcid":false,"given":"Sara","family":"de Lope Qui\u00f1ones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6002-4237","authenticated-orcid":false,"given":"Manuel","family":"Luque-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4871-2379","authenticated-orcid":false,"given":"Alejandra","family":"Quintero Tobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Ruiz C\u00e1novas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4751-3017","authenticated-orcid":false,"given":"Beatriz","family":"Dorado Avenda\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6890-1644","authenticated-orcid":false,"given":"Hector F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9758-9397","authenticated-orcid":false,"given":"L\u00eda","family":"Nattero-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"2973_CR1","doi-asserted-by":"publisher","unstructured":"(2019) Introduction: Standards of Medical Care in Diabetes\u20142019. Diabetes Care 42:S1\u2013S2. https:\/\/doi.org\/10.2337\/dc19-Sint01","DOI":"10.2337\/dc19-Sint01"},{"key":"2973_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/dom.14638","volume":"24","author":"F Gomez-Peralta","year":"2022","unstructured":"Gomez-Peralta F, Choudhary P, Cosson E et al (2022) Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin. Diabetes Obes Metab 24:599\u2013608. https:\/\/doi.org\/10.1111\/dom.14638","journal-title":"Diabetes Obes Metab"},{"key":"2973_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/dc17-0636","volume":"40","author":"RW Beck","year":"2017","unstructured":"Beck RW, Connor CG, Mullen DM et al (2017) The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading. Diabetes Care 40:994\u2013999. https:\/\/doi.org\/10.2337\/dc17-0636","journal-title":"Diabetes Care"},{"key":"2973_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1177\/1932296819883885","volume":"14","author":"L Heinemann","year":"2020","unstructured":"Heinemann L, Freckmann G, M\u00fcller-Wieland D, Kellerer M (2020) Critical reappraisal of the time-in-range: alternative or useful addition to glycated hemoglobin? J Diabetes Sci Technol 14:922\u2013927. https:\/\/doi.org\/10.1177\/1932296819883885","journal-title":"J Diabetes Sci Technol"},{"key":"2973_CR5","doi-asserted-by":"publisher","first-page":"e2221","DOI":"10.1210\/clinem\/dgac034","volume":"107","author":"M Yapanis","year":"2022","unstructured":"Yapanis M, James S, Craig ME et al (2022) Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring. J Clin Endocrinol Metabolism 107:e2221\u2013e2236. https:\/\/doi.org\/10.1210\/clinem\/dgac034","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2973_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.eprac.2023.01.001","volume":"29","author":"R Ibarra-Salce","year":"2023","unstructured":"Ibarra-Salce R, Pozos-Varela FJ, Martinez-Zavala N et al (2023) Correlation Between Hemoglobin Glycation Index Measured by Continuous Glucose Monitoring With Complications in Type 1 Diabetes. Endocr Pract 29:162\u2013167. https:\/\/doi.org\/10.1016\/j.eprac.2023.01.001","journal-title":"Endocr Pract"},{"key":"2973_CR7","doi-asserted-by":"publisher","DOI":"10.12788\/jfp.0514","volume":"72","author":"B Lacy","year":"2023","unstructured":"Lacy B (2023) A patient-centered approach to managing IBS-C and CIC. J Fam Pract 72:0514. https:\/\/doi.org\/10.12788\/jfp.0514","journal-title":"J Fam Pract"},{"key":"2973_CR8","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","volume":"99","author":"DS Wishart","year":"2019","unstructured":"Wishart DS (2019) Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev 99:1819\u20131875. https:\/\/doi.org\/10.1152\/physrev.00035.2018","journal-title":"Physiol Rev"},{"key":"2973_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14080436","volume":"14","author":"MR Insenser","year":"2024","unstructured":"Insenser MR, Nattero-Ch\u00e1vez L, Luque-Ram\u00edrez M et al (2024) Investigating the link between intermediate metabolism, sexual dimorphism, and cardiac autonomic dysfunction in patients with type 1 diabetes. Metabolites 14:436. https:\/\/doi.org\/10.3390\/metabo14080436","journal-title":"Metabolites"},{"key":"2973_CR10","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s40618-023-02289-9","volume":"47","author":"L Nattero-Ch\u00e1vez","year":"2024","unstructured":"Nattero-Ch\u00e1vez L, Insenser M, Amig\u00f3 N et al (2024) Quantification of lipoproteins by proton nuclear magnetic resonance spectroscopy (1H-NMRS) improves the prediction of cardiac autonomic dysfunction in patients with type 1 diabetes. J Endocrinol Invest 47:2075\u20132085. https:\/\/doi.org\/10.1007\/s40618-023-02289-9","journal-title":"J Endocrinol Invest"},{"key":"2973_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15010055","volume":"15","author":"S De Lope Qui\u00f1ones","year":"2025","unstructured":"De Lope Qui\u00f1ones S, Luque-Ram\u00edrez M, Michael Fern\u00e1ndez AC et al (2025) Unveiling silent atherosclerosis in type 1 diabetes: the role of glycoprotein and lipoprotein lipidomics, and cardiac autonomic neuropathy. Metabolites 15:55. https:\/\/doi.org\/10.3390\/metabo15010055","journal-title":"Metabolites"},{"key":"2973_CR12","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care 42:1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"key":"2973_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01766-y","volume":"22","author":"L Nattero-Ch\u00e1vez","year":"2023","unstructured":"Nattero-Ch\u00e1vez L, Insenser M, Quintero Tobar A et al (2023) Sex differences and sex steroids influence on the presentation and severity of cardiovascular autonomic neuropathy of patients with type 1 diabetes. Cardiovasc Diabetol 22:32. https:\/\/doi.org\/10.1186\/s12933-023-01766-y","journal-title":"Cardiovasc Diabetol"},{"key":"2973_CR14","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee, ElSayed NA, Aleppo G et al (2024) 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care 47:S20\u2013S42. https:\/\/doi.org\/10.2337\/dc24-S002","journal-title":"Diabetes Care"},{"key":"2973_CR15","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.2337\/dc24-S004","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee, ElSayed NA, Aleppo G et al (2024) 4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142024. Diabetes Care 47:S52\u2013S76. https:\/\/doi.org\/10.2337\/dc24-S004","journal-title":"Diabetes Care"},{"key":"2973_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01652-z","volume":"21","author":"C Puig-Jov\u00e9","year":"2022","unstructured":"Puig-Jov\u00e9 C, Julve J, Castelblanco E et al (2022) The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. Cardiovasc Diabetol 21:257. https:\/\/doi.org\/10.1186\/s12933-022-01652-z","journal-title":"Cardiovasc Diabetol"},{"key":"2973_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu14193932","volume":"14","author":"J Julve","year":"2022","unstructured":"Julve J, Rossell J, Correig E et al (2022) Predictive value of the advanced lipoprotein profile and glycated proteins on diabetic retinopathy. Nutrients 14:3932. https:\/\/doi.org\/10.3390\/nu14193932","journal-title":"Nutrients"},{"key":"2973_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001221","volume":"3","author":"AO Akinkuolie","year":"2014","unstructured":"Akinkuolie AO, Buring JE, Ridker PM, Mora S (2014) A novel protein glycan biomarker and future cardiovascular disease events. J Am Heart Assoc 3:e001221. https:\/\/doi.org\/10.1161\/JAHA.114.001221","journal-title":"J Am Heart Assoc"},{"key":"2973_CR19","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.numecd.2021.03.021","volume":"31","author":"T Ser\u00e9s-Noriega","year":"2021","unstructured":"Ser\u00e9s-Noriega T, Gim\u00e9nez M, Perea V et al (2021) Quantification of glycoproteins by nuclear magnetic resonance associated with preclinical carotid atherosclerosis in patients with type 1 diabetes. Nutr Metab Cardiovasc Dis 31:2099\u20132108. https:\/\/doi.org\/10.1016\/j.numecd.2021.03.021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2973_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05818-z","volume":"15","author":"E Cecerska-Hery\u0107","year":"2025","unstructured":"Cecerska-Hery\u0107 E, Engwert W, Micha\u0142\u00f3w J et al (2025) Oxidative stress markers and inflammation in type 1 and 2 diabetes are affected by BMI, treatment type, and complications. Sci Rep 15:23605. https:\/\/doi.org\/10.1038\/s41598-025-05818-z","journal-title":"Sci Rep"},{"key":"2973_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107613","volume":"34","author":"S Paul","year":"2020","unstructured":"Paul S, Ali A, Katare R (2020) Molecular complexities underlying the vascular complications of diabetes mellitus \u2013 a comprehensive review. J Diabetes Complications 34:107613. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107613","journal-title":"J Diabetes Complications"},{"key":"2973_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1518746","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, Dong M, Li J et al (2025) The association between stress hyperglycemia and poor outcome in critically ill children is modulated by hyperlactatemia. Front Endocrinol 16:1518746. https:\/\/doi.org\/10.3389\/fendo.2025.1518746","journal-title":"Front Endocrinol"},{"key":"2973_CR23","doi-asserted-by":"publisher","first-page":"1427058","DOI":"10.3389\/fendo.2024.1427058","volume":"15","author":"F Abdallah","year":"2024","unstructured":"Abdallah F, Bazzi S, Akle C et al (2024) Reduction of hyperglycemia in STZ-induced diabetic mice by prophylactic treatment with heat-killed Mycobacterium aurum: possible effects on glucose utilization, mitochondrial uncoupling, and oxidative stress in liver and skeletal muscle. Front Endocrinol 15:1427058. https:\/\/doi.org\/10.3389\/fendo.2024.1427058","journal-title":"Front Endocrinol"},{"key":"2973_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1210\/jc.2015-2640","volume":"101","author":"T Dutta","year":"2016","unstructured":"Dutta T, Kudva YC, Persson X-MT et al (2016) Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic People. J Clin Endocrinol Metabolism 101:1023\u20131033. https:\/\/doi.org\/10.1210\/jc.2015-2640","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2973_CR25","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.2337\/dc14-2205","volume":"38","author":"MCGJ Brouwers","year":"2015","unstructured":"Brouwers MCGJ, Ham JC, Wisse E et al (2015) Elevated Lactate Levels in Patients With Poorly Regulated Type 1 Diabetes and Glycogenic Hepatopathy: A New Feature of Mauriac Syndrome. Diabetes Care 38:e11\u2013e12. https:\/\/doi.org\/10.2337\/dc14-2205","journal-title":"Diabetes Care"},{"key":"2973_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1631302","volume":"13","author":"E \u00d6ge Enver","year":"2025","unstructured":"\u00d6ge Enver E, Duygu A, Vatansever P et al (2025) Plasma amino acid profiles in pediatric obesity: potential biomarkers for the early assessment of metabolic risk. Front Pediatr 13:1631302. https:\/\/doi.org\/10.3389\/fped.2025.1631302","journal-title":"Front Pediatr"},{"key":"2973_CR27","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.70381","volume":"13","author":"JN Velasco-Silva","year":"2025","unstructured":"Velasco-Silva JN, Wilkerson JL, Ramos D et al (2025) Loss of hepatic autophagy induces \u03b1\u2010cell proliferation through impaired glutamine\u2010dependent gluconeogenesis. Physiol Rep 13:e70381. https:\/\/doi.org\/10.14814\/phy2.70381","journal-title":"Physiol Rep"},{"key":"2973_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s10616-025-00844-1","volume":"77","author":"G Aydogdu","year":"2025","unstructured":"Aydogdu G, Sermikli BP, Aras S, Yilmaz E (2025) The role of glutamine metabolism and ASCT2\/SLC1A5 transporter on insulin resistance and endoplasmic reticulum stress in 3T3-L1 adipocytes. Cytotechnology 77:177. https:\/\/doi.org\/10.1007\/s10616-025-00844-1","journal-title":"Cytotechnology"},{"key":"2973_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MCO.0000000000000530","volume":"22","author":"D Darmaun","year":"2019","unstructured":"Darmaun D, Torres-Santiago L, Mauras N (2019) Glutamine and type 1 diabetes mellitus: is there a role in glycemic control? Curr Opin Clin Nutr Metab Care 22:91\u201395. https:\/\/doi.org\/10.1097\/MCO.0000000000000530","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2973_CR30","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1210\/jc.2018-00546","volume":"103","author":"F Ottosson","year":"2018","unstructured":"Ottosson F, Smith E, Melander O, Fernandez C (2018) Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes. J Clin Endocrinol Metabolism 103:3060\u20133069. https:\/\/doi.org\/10.1210\/jc.2018-00546","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2973_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164807","volume":"11","author":"S-A Cha","year":"2016","unstructured":"Cha S-A, Yun J-S, Lim T-S et al (2016) Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes. PLoS One 11:e0164807. https:\/\/doi.org\/10.1371\/journal.pone.0164807","journal-title":"PLoS One"},{"key":"2973_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1586\/eem.12.30","volume":"7","author":"AA Rizvi","year":"2012","unstructured":"Rizvi AA, Montalto G, Patti AM, Rizzo M (2012) Oxidative stress and small, dense low-density lipoproteins: current and future perspectives. Expert Rev Endocrinol Metabolism 7:415\u2013417. https:\/\/doi.org\/10.1586\/eem.12.30","journal-title":"Expert Rev Endocrinol Metabolism"},{"key":"2973_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0002-9343(00)00700-2","volume":"110","author":"DL Tribble","year":"2001","unstructured":"Tribble DL, Rizzo M, Chait A et al (2001) Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. Am J Med 110:103\u2013110. https:\/\/doi.org\/10.1016\/S0002-9343(00)00700-2","journal-title":"Am J Med"},{"key":"2973_CR34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4093\/dmj.2011.35.5.536","volume":"35","author":"S Suh","year":"2011","unstructured":"Suh S, Park H-D, Kim SW et al (2011) Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients. Diabetes Metab J 35:536. https:\/\/doi.org\/10.4093\/dmj.2011.35.5.536","journal-title":"Diabetes Metab J"},{"key":"2973_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/014572178801400508","volume":"14","author":"PE Cryer","year":"1988","unstructured":"Cryer PE (1988) Hypoglycemia: The Limiting Factor in the Management of Insulin-Dependent Diabetes Mellitus. Diabetes Educ 14:407\u2013411. https:\/\/doi.org\/10.1177\/014572178801400508","journal-title":"Diabetes Educ"},{"key":"2973_CR36","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/jamainternmed.2014.136","volume":"174","author":"AI Geller","year":"2014","unstructured":"Geller AI, Shehab N, Lovegrove MC et al (2014) National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations. JAMA Intern Med 174:678. https:\/\/doi.org\/10.1001\/jamainternmed.2014.136","journal-title":"JAMA Intern Med"},{"key":"2973_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.111011","volume":"206","author":"A Rossi","year":"2023","unstructured":"Rossi A, Montefusco L, Reseghetti E et al (2023) Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system. Diabetes Res Clin Pract 206:111011. https:\/\/doi.org\/10.1016\/j.diabres.2023.111011","journal-title":"Diabetes Res Clin Pract"},{"key":"2973_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003327","volume":"11","author":"R She","year":"2023","unstructured":"She R, Al-sari NH, Mattila IM et al (2023) Decreased branched-chain amino acids and elevated fatty acids during antecedent hypoglycemia in type 1 diabetes. BMJ Open Diabetes Res Care 11:e003327. https:\/\/doi.org\/10.1136\/bmjdrc-2023-003327","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2973_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/B:MCBI.0000026067.08356.13","volume":"260","author":"P Singh","year":"2004","unstructured":"Singh P, Jain A, Kaur G (2004) Impact of hypoglycemia and diabetes on CNS: Correlation of mitochondrial oxidative stress with DNA damage. Mol Cell Biochem 260:153\u2013159. https:\/\/doi.org\/10.1023\/B:MCBI.0000026067.08356.13","journal-title":"Mol Cell Biochem"},{"key":"2973_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3785","volume":"40","author":"A Mesa","year":"2024","unstructured":"Mesa A, Gim\u00e9nez M, Perea V et al (2024) Severe hypoglycemia and hypoglycemia awareness are associated with preclinical atherosclerosis in patients with type 1 diabetes without an estimated high cardiovascular risk. Diabetes Metab Res Rev 40:e3785. https:\/\/doi.org\/10.1002\/dmrr.3785","journal-title":"Diabetes Metab Res Rev"},{"key":"2973_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030518","volume":"15","author":"L Zhang","year":"2023","unstructured":"Zhang L, Guo K, Tian Q et al (2023) Serum metabolomics reveals a potential benefit of methionine in type 1 diabetes patients with poor glycemic control and high glycemic variability. Nutrients 15:518. https:\/\/doi.org\/10.3390\/nu15030518","journal-title":"Nutrients"},{"key":"2973_CR42","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s13300-024-01648-w","volume":"15","author":"AH Heald","year":"2024","unstructured":"Heald AH, Stedman M, Levy JW et al (2024) The Relation of Diabetes Complications to a New Interpretation of Glycaemic Variability from Continuous Glucose Monitoring in People with Type 1 Diabetes. Diabetes Ther 15:2489\u20132498. https:\/\/doi.org\/10.1007\/s13300-024-01648-w","journal-title":"Diabetes Ther"},{"key":"2973_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052611","volume":"8","author":"M Salvucci","year":"2013","unstructured":"Salvucci M, Neufeld Z, Newsholme P (2013) Mathematical model of metabolism and electrophysiology of amino acid and glucose stimulated insulin secretion: in vitro validation using a \u03b2-cell line. PLoS ONE 8:e52611. https:\/\/doi.org\/10.1371\/journal.pone.0052611","journal-title":"PLoS ONE"},{"key":"2973_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001315","volume":"8","author":"SH Gunther","year":"2020","unstructured":"Gunther SH, Khoo CM, Tai E-S et al (2020) Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population. BMJ Open Diab Res Care 8:e001315. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001315","journal-title":"BMJ Open Diab Res Care"},{"key":"2973_CR45","unstructured":"Metabolomics and type 2 diabetes risk An updated systematic review and meta-analysis of prospective cohort studies"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02973-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02973-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02973-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:33:43Z","timestamp":1790757223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02973-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2973"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02973-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee of Hospital Universitario Ram\u00f3n y Cajal (Date of approval: 25 September 2017; Protocol ID: 189\u2009\u2212\u200917).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}